Incarcerated women are at increased risk of developing cervical cancer and have high rates of human papillomavirus (HPV) infection, an important cause of cervical cancer. However, many correctional facilities do not offer HPV vaccination to female inmates. This pilot survey study, conducted with incarcerated women aged 18 to 26 at a facility that does not offer the vaccine, assessed attitudes and knowledge about HPV and the HPV vaccine, acceptability of and barriers to in-prison HPV vaccination, and self-reported HPV vaccination rates. Most participants reported that they had not received the HPV vaccine but had positive attitudes toward it and would be willing to get it in prison. Correctional facilities should consider offering this preventive service to this vulnerable population.
BermanT. A., SchillerJ. T. (2017). Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer, 123, 2219–2229.
3.
BeshersS. C., MurphyJ. M., FixB. V., MahoneyM. C. (2015). Sex differences among college students in awareness of the human papillomavirus vaccine and vaccine options. Journal of American College Health, 63, 144–147.
4.
BickellN. A., VermundS. H., HolmesM., SafyerS., BurkR. D. (1991). Human papillomavirus, gonorrhea, syphilis, and cervical dysplasia in jailed women. American Journal of Public Health, 81, 1318–1320.
5.
BinswangerI. A., KruegerP. M., SteinerJ. F. (2009). Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. Journal of Epidemiology and Community Health, 63, 912–919.
6.
BinswangerI. A., MuellerS., ClarkC. B., CropseyK. L. (2011). Risk factors for cervical cancer in criminal justice settings. Journal of Womens Health, 20, 1839–1845.
7.
BlakeK. D., OttenbacherA. J., Finney RuttenL. J., GradyM. A., KobrinS. C., JacobsonR. M., HesseB. W. (2015). Predictors of human papillomavirus awareness and knowledge in 2013: Gaps and opportunities for targeted communication strategies. American Journal of Preventive Medicine, 48, 402–410.
8.
BondS. M., CartmellK. B., LopezC. M., FordM. E., BrandtH. M., GoreE. I.…AlbergA. J. (2016). Racial and ethnic group knowledge, perceptions and behaviors about human papillomavirus, human papillomavirus vaccination, and cervical cancer among adolescent females. Journal of Pediatric and Adolescent Gynecology, 29, 429–435.
9.
BurakL. J., MeyerM. (1997). Using the health belief model to examine and predict college women’s cervical cancer screening beliefs and behavior. Health Care for Women International, 18, 251–262.
10.
BynumS. A., BrandtH. M., FriedmanD. B., AnnangL., TannerA. (2011). Knowledge, beliefs, and behaviors: Examining human papillomavirus-related gender differences among African American college students. Journal of American College Health, 59, 296–302.
de SanjoséS., VallsI., Paz CañadasM., LloverasB., QuintanaM. J., ShahK. V., BoschF. X. (2000). Infección por los virus del papiloma humano y de la inmunodeficiencia humana como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas [Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners]. Medicina Clinica, 115, 81–84.
15.
DempseyA. F., ZimetG. D., DavisR. L., KoutskyL. (2006). Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics, 117, 1486–1493.
16.
GalbraithK. V., LechugaJ., JeneretteC. M., MooreL. A., PalmerM. H., HamiltonJ. B. (2016). Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: A literature review. Social Science & Medicine, 159, 116–126.
17.
GanderS., ScholtenV., OsswaldI., SuttonM., van WylickR. (2009). Cervical dysplasia and associated risk factors in a juvenile detainee population. Journal of Pediatric and Adolescent Gynecology, 22, 351–355.
18.
GarciniL. M., MurrayK. E., Barnack-TavlarisJ. L., ZhouA. Q., MalcarneV. L., KlonoffE. A. (2015). Awareness and knowledge of human papillomavirus (HPV) among ethnically diverse women varying in generation status. Journal of Immigrant and Minority Health, 17, 29–36.
19.
GerendM. A., LeeS. C., ShepherdJ. E. (2007). Predictors of human papillomavirus vaccination acceptability among underserved women. Sexually Transmitted Diseases, 34, 468–471.
20.
GerendM. A., MagloireZ. F. (2008). Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. Journal of Adolescent Health, 42, 237–242.
21.
GlennB. A., TsuiJ., SinghalR., SanchezL., NonzeeN. J., ChangL. C.…BastaniR. (2015). Factors associated with HPV awareness among mothers of low-income ethnic minority adolescent girls in Los Angeles. Vaccine, 33, 289–293.
HarrisP. A., TaylorR., ThielkeR., PayneJ., GonzalezN., CondeJ. G. (2009). Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42, 377–381.
24.
HendersonC. E., RichJ. D., LallyM. A. (2010). HPV vaccination practices among juvenile justice facilities in the United States. Journal of Adolescent Health, 46, 495–498.
25.
HothornT., BuhlmannP., DudoitS., MolinaroA., van der LaanM. J. (2006). Survival ensembles. Biostatistics, 7, 355–373.
26.
HowertonA., ByngR., CampbellJ., HessD., OwensC., AitkenP. (2007). Understanding help seeking behaviour among male offenders: Qualitative interview study. British Medical Journal, 334, 303.
27.
JanitzaS., TutzG., BoulesteixA.-L. (2016). Random forest for ordinal responses: Prediction and variable selection. Computational Statistics & Data Analysis, 96, 57–73.
28.
KahnJ. A., RosenthalS. L., HamannT., BernsteinD. I. (2003). Attitudes about human papillomavirus vaccine in young women. International Journal of STD & AIDS, 14, 300–306.
29.
LallyM., GaitanisM., VallabhaneniS., ReinertS., MayerK., ZimetG., RichJ. (2006). Willingness to receive an HIV vaccine among incarcerated persons. Preventive Medicine, 43, 402–405.
30.
LechugaJ., Vera-CalaL., Martinez-DonateA. (2016). HPV vaccine awareness, barriers, intentions, and uptake in Latina women. Journal of Immigrant and Minority Health, 18, 173–178.
31.
LloydJ. E., Delaney-ThieleD., AbbottP., BaldryE., McEntyreE., ReathJ.…HarrisM. F. (2015). The role of primary health care services to better meet the needs of Aboriginal Australians transitioning from prison to the community. BMC Family Practice, 16, 86.
32.
MageeC. G., HultJ. R., TuralbaR., McMillanS. (2005). Preventive care for women in prison: A qualitative community health assessment of the Papanicolaou test and follow-up treatment at a California state women’s prison. American Journal of Public Health, 95, 1712–1717.
33.
MarlowL. A., ZimetG. D., McCafferyK. J., OstiniR., WallerJ. (2013). Knowledge of human papillomavirus (HPV) and HPV vaccination: An international comparison. Vaccine, 31, 763–769.
34.
MathewP., EltingL., CooksleyC., OwenS., LinJ. (2005). Cancer in an incarcerated population. Cancer, 104, 2197–2204.
35.
MorrisR. E., HarrisonE. A., KnoxG. W., TromanhauserE., MarquisD. K., WattsL. L. (1995). Health risk behavioral survey from 39 juvenile correctional facilities in the United States. Journal of Adolescent Health, 17, 334–344.
36.
MostashariF., RileyE., SelwynP. A., AlticeF. L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 341–348.
37.
NelsonR. (2012). Challenges to health care delivery in U.S. prisons. American Journal of Nursing, 112, 19–20.
38.
NijhawanA. E., SallowayR., NunnA. S., PoshkusM., ClarkeJ. G. (2010). Preventive healthcare for underserved women: Results of a prison survey. Journal of Women’s Health, 19, 17–22.
39.
PankeyT., RamaswamyM. (2015). Incarcerated women’s HPV awareness, beliefs, and experiences. International Journal of Prisoner Health, 11, 49–58.
40.
PriceJ. H., EastonA. N., TelljohannS. K., WallaceP. B. (1996). Perceptions of cervical cancer and Pap smear screening behavior by women’s sexual orientation. Journal of Community Health, 21, 89–105.
41.
The R Foundation. (2018). The R project for statistical computing. Retrieved from https://www.R-project.org/
42.
RamaswamyM., LeeJ., WickliffeJ., AllisonM., EmersonA., KellyP. J. (2017). Impact of a brief intervention on cervical health literacy: A waitlist control study with jailed women. Preventive Medicine Reports, 6, 314–321.
43.
ScarinciI. C., Garces-PalacioI. C., PartridgeE. E. (2007). An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Women’s Health, 16, 1224–1233.
44.
SequeraV. G., ValenciaS., Garcia-BasteiroA. L., MarcoA., BayasJ. M. (2015). Vaccinations in prisons: A shot in the arm for community health. Human Vaccines & Immunotherapeutics, 11, 2615–2626.
45.
ShermanS. M., NailerE., MinshallC., CoombesR., CooperJ., RedmanC. W. (2016). Awareness and knowledge of HPV and cervical cancer in female students: A survey (with a cautionary note). Journal of Obstetrics and Gynaecology, 36, 76–80.
46.
StroblC., BoulesteixA. L., KneibT., AugustinT., ZeileisA. (2008). Conditional variable importance for random forests. BMC Bioinformatics, 9, 307.
47.
StroblC., BoulesteixA. L., ZeileisA., HothornT. (2007). Bias in random forest variable importance measures: Illustrations, sources and a solution. BMC Bioinformatics, 8, 25.
48.
StrohlA. E., MendozaG., GhantM. S., CameronK. A., SimonM. A., SchinkJ. C., MarshE. E. (2015). Barriers to prevention: Knowledge of HPV, cervical cancer, and HPV vaccinations among African American women. American Journal of Obstetrics & Gynecology, 212, 65.e1–65.e5.
49.
VallabhaneniS., MacalinoG. E., ReinertS. E., SchwartzapfelB., WolfF. A., RichJ. D. (2004). Prisoners’ attitudes toward hepatitis B vaccination. Preventive Medicine, 38, 828–833.
50.
WatkinsK. L., ReitzelL. R., WetterD. W., McNeillL. H. (2015). HPV awareness, knowledge and attitudes among older African-American women. American Journal of Health Behavior, 39, 205–211.
51.
WiddiceL. E., BernsteinD. I., LeonardA. C., MarsoloK. A., KahnJ. A. (2011). Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics, 127, 77–84.
52.
WieheS. E., BaraiN., RosenmanM. B., AalsmaM. C., ScanlonM. L., FortenberryJ. D. (2015). Test positivity for chlamydia, gonorrhea, and syphilis infection among a cohort of individuals released from jail in Marion County, Indiana. Sexually Transmitted Diseases, 42, 30–36.
53.
WilliamsW. W., LuP. J., O’HalloranA., KimD. K., GrohskopfL. A., PilishviliT.…BridgesC. (2016). Surveillance of vaccination coverage among adult populations—United States, 2014. MMWR Surveillance Summaries, 65, 1–36.
ZimetG. D., MaysR. M., WinstonY., KeeR., DickesJ., SuL. (2000). Acceptability of human papillomavirus immunization. Journal of Women’s Health & Gender-Based Medicine, 9, 47–50.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
